| NCT05076253 | Bangkok Metropolitan Administration Medical College and Vajira Hospital | Safety|SARS-CoV2 Infection|Ivermectin Poisoning|Effect of Drug | 2021-09-01 | PHASE1|PHASE2 |
| NCT04482686 | ProgenaBiome | COVID|Covid-19|Corona Virus Infection|Coronavirus Infection|Coronavirus-19|SARS-CoV2|SARS-CoV Infection | 2020-12-09 | PHASE1 |
| NCT02045069 | Mahidol University|Ministry of Health, Thailand | Dengue Fever | 2014-02 | PHASE2|PHASE3 |
| NCT03238131 | University Hospitals Cleveland Medical Center|Washington University School of Medicine | Onchocerciasis | 2012-04 | PHASE3 |
| NCT05930002 | Ain Shams University | COVID-19 | 2021-07-21 | NA |
| NCT04523831 | Dhaka Medical College | Covid19 | 2020-06-01 | PHASE3 |
| NCT03576313 | London School of Hygiene and Tropical Medicine|Institute of Tropical Medicine, Belgium|National Malaria Control Programme, The Gambia|Liverpool School of Tropical Medicine|Radboud University Medical Center|University of Durham|Imperial College London | Malaria | 2018-08-11 | PHASE3 |
| NCT05213585 | Helm Vision Group | The Focus of the Study is to Assess the Effectiveness of Topical Ivermectin on Eliminating Eyelash Sleeves | 2021-08-24 | PHASE1 |
| NCT04834115 | Universidad Nacional de Asunción|Consejo Nacional de Ciencias y Tecnologia, Paraguay|Ministerio de Salud Pública y Bienestar Social, Paraguay|Centro de información y recursos para el desarrollo, Paraguay|Centro para el Desarrollo de la Investigación Científica, CEDIC, Paraguay|Instituto Desarrollo, Paraguay | Covid19|Coronavirus Infection | 2020-11-17 | PHASE3 |
| NCT05246072 | Ain Shams University | COVID-19 | 2021-11-01 | PHASE4 |
| NCT06251739 | International Centre for Diarrhoeal Disease Research, Bangladesh | Post-kala-azar Dermal Leishmaniasis | 2023-10-30 | EARLY_PHASE1 |
| NCT02795117 | Padagis LLC | Rosacea | 2016-05 | PHASE3 |
| NCT05283954 | Oriol Mitja|National Department of Health, Papua New Guinea|Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | SARS-CoV2 Infection|COVID-19 | 2022-05-01 | PHASE2|PHASE3 |
| NCT04529525 | Instituto de Cardiología de Corrientes | Covid19 | 2020-08-19 | PHASE2|PHASE3 |
| NCT04886362 | Ayudas Diagnosticas Sura S.A.S | COVID-19 Pneumonia | 2021-07 | PHASE2|PHASE3 |
| NCT04551755 | Bangladesh Medical Research Council (BMRC) | Covid19 | 2020-09 | PHASE2 |
| NCT01493947 | Galderma R&D | Papulopustular Rosacea | 2012-04 | PHASE3 |
| NCT02407782 | University Hospital, Bordeaux | Scabies | 2016-01-19 | PHASE3 |
| NCT03676140 | Lihir Medical Centre|London School of Hygiene and Tropical Medicine | Trachoma|Yaws|Lymphatic Filariases|Scabies|Strongyloidiasis | 2018-10-01 | PHASE3 |
| NCT07487805 | University of Florida | Solid Tumor, Adult | 2026-07 | PHASE2 |
| NCT01586169 | Centre d´Appui à la lutte contre la Maladie|International Trachoma Initiative | Parasitic Diseases|Bacterial Diseases | 2010-02 | NA |
| NCT02509481 | Colorado State University|Institut de Recherche en Sciences de la Sante, Burkina Faso|Centre Muraz|Ministère de la Santé du Burkina Faso | Malaria|Lymphatic Filariasis | 2015-06 | PHASE2|PHASE3 |
| NCT04700423 | Jennifer Keiser|Public Health Laboratory Ivo de Carneri | Trichuriasis|Ascariasis|Hookworm Infections|Helminthes; Infestation, Intestinal | 2021-03-01 | PHASE2|PHASE3 |
| NCT05060666 | Infectopharm Arzneimittel GmbH|GKM Gesellschaft für Therapieforschung mbH | Covid19 | 2021-11 | PHASE3 |
| NCT03517462 | Washington University School of Medicine|Case Western Reserve University|University of Health and Allied Sciences | Onchocerciasis | 2018-08-06 | NA |
| NCT07159373 | Medicines Development for Global Health|Murdoch Childrens Research Institute|Kirby Institute | Lymphatic Filariasis|Scabies|Strongyloidiasis | 2026-03 | PHASE3 |
| NCT02841215 | Assistance Publique - H?pitaux de Paris | Gale|Severe Forms of Scabies|Oral Parasitic Drug|Ivermectin | 2017-10-11 | PHASE3 |
| NCT01213576 | London School of Hygiene and Tropical Medicine|Emory University | Lymphatic Filariasis | 2009-01 | NA |
| NCT05041907 | University of Oxford | COVID-19 | 2021-09-30 | PHASE2 |
| NCT03527732 | Jennifer Keiser|Centre Suisse de Recherches Scientifiques en Cote d´Ivoire|Lao Tropical and Public Health Institute|Public Health Laboratory of Pemba, Tanzania | Trichuriasis | 2018-09-09 | PHASE2|PHASE3 |
| NCT03664063 | Lihir Medical Centre | Lymphatic Filariasis|Yaws|Trauma | 2018-09-01 | PHASE2 |
| NCT04779047 | October 6 University|Beni-Suef University | Covid19|Pneumonia | 2020-10-01 | PHASE4 |
| NCT04701710 | Maria de los Angeles Peral de Bruno | Covid19|SARS (Severe Acute Respiratory Syndrome) | 2020-10-15 | PHASE1|PHASE2 |
| NCT02806414 | University of California, San Diego|Galderma R&D | Rosacea | 2016-07 | PHASE1|PHASE2 |
| NCT03236168 | London School of Hygiene and Tropical Medicine | Scabies|Head Lice | 2017-08-01 | PHASE3 |
| NCT04712279 | Corpometria Institute | Covid19 | 2021-01-25 | PHASE2|PHASE3 |
| NCT04944082 | Assiut University | Covid19 | 2021-07-01 | PHASE4 |
| NCT05082753 | Humanis Sagl?k Anonim Sirketi | Anthelmintic Agent | 2020-11-19 | PHASE1 |
| NCT04407507 | Investigacion Biomedica para el Desarrollo de Farmacos S.A. de C.V. | COVID-19 | 2020-07-01 | PHASE2 |
| NCT02511353 | Liverpool School of Tropical Medicine|Kenya Medical Research Institute|Centers for Disease Control and Prevention | Malaria | 2015-07 | PHASE2 |
| NCT00765024 | Mahidol University|Atlantic Laboratory Ltd | Chronic Strongyloidiasis | 2008-07 | PHASE3 |
| NCT03036059 | Noguchi Memorial Institute for Medical Research|Ghana Health Services | Lymphatic Filariasis|Helminth Infection | 2017-05-19 | PHASE4 |
| NCT06259383 | Prince of Songkla University | Clinical Syndrome | 2018-01-01 | PHASE3 |
| NCT02236403 | Universidad Nacional de Colombia | Chronic Blepharitis | 2014-10 | PHASE3 |
| NCT02840461 | Actavis Inc. | Moderate to Severe Papulopustular Rosacea | 2016-06 | PHASE3 |
| NCT04784481 | Ministry of Public Health, Argentina | Covid19|SARS (Severe Acute Respiratory Syndrome) | 2020-09-20 | PHASE1|PHASE2 |
| NCT04681053 | Mansoura University | COVID-19 | 2021-02-25 | PHASE3 |
| NCT05993143 | Insud Pharma | COVID-19|SARS-CoV-2 | 2021-01-18 | PHASE3 |
| NCT05040724 | Raincy Montfermeil Hospital Group | To Assess the Reduction in the Viral Load of SARS-CoV-2 in Patients Receiving Ivermectin Compared to Those Receiving Standard Care | 2021-05-28 | PHASE3 |
| NCT04108897 | Johns Hopkins University | Rosacea | 2019-09-17 | EARLY_PHASE1 |
| NCT02032043 | Washington University School of Medicine | Lymphatic Filariasis|Onchocerciasis|Soil Transmitted Helminth (STH) Infections | 2014-02 | |
| NCT00988533 | Topaz Pharmaceuticals Inc | Head Lice | 2009-09 | PHASE1 |
| NCT04527211 | Javeriana University | Covid19|Healthcare Worker Patient Transmission | 2020-09-07 | PHASE3 |
| NCT04410406 | Washington University School of Medicine|Case Western Reserve University|Centre Suisse de Recherches Scientifiques en Cote d´Ivoire | Lymphatic Filariasis | 2020-08-20 | PHASE3 |
| NCT03257943 | Sun Pharmaceutical Industries, Inc. | Lice; Head Lice | 2017-03-20 | PHASE1 |
| NCT03074435 | Institut de Recherche pour le Developpement|Institut de Recherche en Sciences de la Sante, Burkina Faso|Institut Pierre Richet | Malaria | 2016-07 | PHASE3 |
| NCT04425863 | Eurnekian Public Hospital | Severe Acute Respiratory Syndrome|Ventilation Pneumonitis | 2020-05-01 | |
| NCT00994422 | Topaz Pharmaceuticals Inc | Head Lice | 2009-10 | PHASE2 |
| NCT04425707 | Ministry of Health and Population, Egypt | Covid19 | 2020-06-09 | NA |
| NCT04602507 | CES University | Covid19|Severe Acute Respiratory Syndrome | 2020-12-10 | PHASE2 |
| NCT00921219 | Johnson & Johnson Consumer and Personal Products Worldwide | Healthy | 2005-09 | PHASE1 |
| NCT06070116 | Washington University School of Medicine|National Public Health Institute of Liberia | Onchocercal Subcutaneous Nodule|Onchocerciasis|Onchocerciasis, Ocular|Onchocerca Infection|Tropical Disease | 2024-04-05 | PHASE2 |
| NCT04446104 | National University Hospital, Singapore | Covid-19 | 2020-05-13 | PHASE3 |
| NCT04460547 | Qassim University | COVID-19 | 2020-07-25 | |
| NCT05085665 | Washington University School of Medicine|Center for Research on Filariasis and Other Tropical Diseases, Cameroon | Loiasis | 2021-07-30 | PHASE4 |
| NCT00215280 | DBL -Institute for Health Research and Development|Ministry of Health, Uganda | Mansonelliasis|Pruritus|Lymphoedema|Abdominal Pains | 2005-11 | NA |
| NCT03553615 | Stanford University | Atopic Dermatitis | 2030-12-01 | PHASE2 |
| NCT06918665 | Murdoch Childrens Research Institute|Monash University | Scabies | 2026-07 | PHASE1 |
| NCT03570814 | London School of Hygiene and Tropical Medicine|Armauer Hansen Research Institute, Ethiopia|Federal Minstry of Health of Ethiopia | Trachoma|Lymphatic Filariases | 2021-12-01 | PHASE4 |
| NCT04966702 | Barcelona Institute for Global Health|UNITAID | Malaria | 2022-03-17 | PHASE3 |
| NCT05155527 | Mahidol University|Prince of Songkla University | COVID-19 | 2022-02-10 | PHASE2 |
| NCT01050517 | DBL -Institute for Health Research and Development | Parasitic Diseases | 2007-10 | NA |
| NCT04951362 | South Valley University | Anosmia | 2021-04-20 | PHASE2|PHASE3 |
| NCT03578679 | Institut de Recherche pour le Developpement | Pediculoses | 2018-07-11 | NA |
| NCT04431466 | Universidade Federal de Sao Carlos | Coronavirus Infection | 2020-07-01 | PHASE2 |
| NCT03605758 | Albert Einstein College of Medicine | Strongyloides Stercoralis Infection|Strongyloidiasis | 2012-05 | PHASE3 |
| NCT04723459 | South Valley University | Covid-19 | 2021-01-23 | NA |
| NCT04894721 | Ministry of Public Health, Argentina | Covid19 | 2021-06-01 | PHASE2|PHASE3 |
| NCT00790998 | Medicines Development for Global Health|World Health Organization | Onchocerciasis | 2009-04 | PHASE3 |
| NCT01903057 | Emory University | Trachoma|Lymphatic Filariasis | 2014-02 | PHASE4 |
| NCT05819983 | Universitas Padjadjaran | Scabies | 2023-01-25 | PHASE4 |
| NCT04390022 | Clinica Universidad de Navarra, Universidad de Navarra|Barcelona Institute for Global Health | Covid-19|Coronavirus Infection|SARS-CoV-2 Infection | 2020-07-31 | PHASE2 |
| NCT05318469 | Yuan Yuan|Agenus Inc.|Gateway for Cancer Research | Anatomic Stage IV Breast Cancer AJCC v8|Metastatic Triple-Negative Breast Carcinoma | 2023-10-13 | PHASE1|PHASE2 |
| NCT00300768 | Medicines Development for Global Health|World Health Organization | Onchocerciasis | 2006-09-06 | PHASE2 |
| NCT04673214 | Gilberto Cruz Arteaga|Coordinación de Investigación en Salud, Mexico | Covid19 | 2020-12-16 | PHASE3 |
| NCT02974049 | University Hospitals Cleveland Medical Center|Washington University School of Medicine | Lymphatic Filariasis | 2015-01 | NA |
| NCT03337490 | Mayne Pharma International Pty Ltd|bioRASI, LLC | Head Lice | 2017-10-02 | PHASE3 |
| NCT05894538 | Susanna Naggie, MD|National Center for Advancing Translational Sciences (NCATS)|Vanderbilt University Medical Center | Covid19 | 2022-02-16 | PHASE3 |
| NCT04384458 | Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara | Coronavirus Infections | 2020-07-20 | NA |
| NCT06332872 | Phramongkutklao College of Medicine and Hospital | Pediculus Capitis Infestation|Permethrin Adverse Reaction|Dimethicone Adverse Reaction|Permethrin Allergy|Dimethicone Allergy|Ivermectin|School-age Children | 2023-12-15 | PHASE4 |
| NCT07396714 | Assiut University | Warts | 2026-02-01 | EARLY_PHASE1 |
| NCT06184399 | Jennifer Keiser|Public Health Laboratory Ivo de Carneri | Trichuriasis|Ascariasis|Hookworm Infections | 2024-06-05 | PHASE2 |
| NCT04920942 | Clinical Research Centre, Malaysia | COVID-19 | 2021-05-31 | PHASE3 |
| NCT05736861 | Susanna Naggie, MD|National Center for Advancing Translational Sciences (NCATS)|Vanderbilt University Medical Center | Covid19 | 2021-06-08 | PHASE3 |
| NCT00921674 | Johnson & Johnson Consumer and Personal Products Worldwide | Healthy | 2005-02 | PHASE1 |
| NCT02845713 | University Hospitals Cleveland Medical Center|Washington University School of Medicine | Wuchereria Bancrofti Infection | 2016-04-17 | PHASE1 |
| NCT04438850 | IRCCS Sacro Cuore Don Calabria di Negrar|Istituto Di Ricerche Farmacologiche Mario Negri | Covid19 | 2020-07-31 | PHASE2 |
| NCT01975441 | University Hospitals Cleveland Medical Center | Lymphatic Filariasis | 2014-05 | PHASE2 |
| NCT04937569 | Assiut University | Covid19 | 2021-07-01 | PHASE3 |
| NCT04668469 | Benha University | Covid19 | 2020-06-08 | NA |
| NCT04510194 | University of Minnesota|UnitedHealth Group|Northwestern University|Hennepin County Medical Center, Minneapolis|University of Colorado, Denver|Olive View-UCLA Education & Research Institute | Covid19|SARS-CoV Infection | 2021-01-01 | PHASE3 |
| NCT04399746 | Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado | COVID | 2020-03-15 | NA |
| NCT04635943 | Universidad Peruana Cayetano Heredia|Barcelona Institute for Global Health | Covid19|Coronavirus Infection|SARS-CoV Infection | 2020-08-29 | PHASE2 |
| NCT05500326 | Murdoch Childrens Research Institute|Burnet Institute|Lao Tropical and Public Health Institute | Scabies; Itch|Scabies | 2025-06-24 | PHASE2 |
| NCT05643820 | Combined Military Hospital Abbottabad | Pediculosis | 2022-03-01 | PHASE1 |
| NCT04392427 | Mansoura University | COVID|Drug Effect | 2020-10 | PHASE3 |
| NCT04510233 | Tanta University | Covid19 | 2020-09 | PHASE2 |
| NCT04403555 | Tanta University | COVID | 2020-06-01 | PHASE2|PHASE3 |
| NCT03075891 | Galderma R&D | Rosacea | 2017-07-05 | PHASE4 |
| NCT04311671 | Medicines Development for Global Health | Onchocerciasis | 2021-05-03 | PHASE3 |
| NCT03852303 | Universiteit Antwerpen|European Research Council | Epilepsy | 2017-10-01 | PHASE4 |
| NCT04106726 | Zydus Worldwide DMCC|Catawba Research, LLC | Facial Rosacea | 2019-10-17 | PHASE3 |
| NCT01593722 | National Institute of Allergy and Infectious Diseases (NIAID) | Loiasis | 2012-04 | PHASE4 |
| NCT04726969 | Jennifer Keiser|Centre Suisse de Recherches Scientifiques en Cote d´Ivoire | Trichuriasis|Ascariasis|Hookworm Infections | 2021-06-15 | PHASE3 |
| NCT04407130 | International Centre for Diarrhoeal Disease Research, Bangladesh | COVID-19 Patients | 2020-06-16 | PHASE2 |
| NCT03052998 | Robert Colebunders | Ivermectin|Onchocerciasis|Epilepsy | 2017-10-01 | PHASE4 |
| NCT04747678 | Menoufia University | Covid19|Ivermectin Poisoning|Drug Toxicity|Drug Side Effect | 2021-02-03 | |
| NCT04351347 | Tanta University | COVID | 2020-06-16 | PHASE2|PHASE3 |
| NCT03301649 | Actavis Inc.|Teva Pharmaceuticals USA | Head Lice | 2017-10-07 | PHASE3 |
| NCT05231603 | Clinical Research Centre, Malaysia|Hovid Berhad | COVID-19 | 2022-02-16 | PHASE3 |
| NCT04425850 | Eurnekian Public Hospital | Covid19 | 2020-06-01 | |
| NCT04445311 | Zagazig University | COVID | 2020-05-31 | PHASE2|PHASE3 |
| NCT03717558 | Pierre Fabre Dermatology | Healthy Volunteers | 2018-04-30 | PHASE1 |
| NCT04891250 | Centre for Infectious Disease Research in Zambia|Ministry of Health, Zambia|University of Zambia | SARS-CoV-2|Ivermectin | 2021-10 | PHASE4 |
| NCT05305560 | MedinCell S.A|Violaine Desort-Hénin, DVM | COVID-19 | 2022-03-25 | PHASE2 |
| NCT04056325 | Jennifer Keiser|National Institute of Public Health, Vientiane, Laos | Strongyloides Stercoralis Infection | 2019-11-27 | PHASE2|PHASE3 |
| NCT00817713 | Swiss Tropical & Public Health Institute|Ifakara Health Research and Development Centre|Insel Gruppe AG, University Hospital Bern|Merck KGaA, Darmstadt, Germany | HIV Infections|Helminthiasis | 2009-01 | NA |
| NCT04447235 | Instituto do Cancer do Estado de S?o Paulo | Cancer|COVID|Coronavirus Infection | 2020-07-23 | PHASE2 |
| NCT04632706 | MedinCell S.A | Covid19 | 2020-09-22 | PHASE1 |
| NCT04739410 | FMH College of Medicine and Dentistry | Covid19 | 2020-05-01 | PHASE4 |
| NCT05946642 | Malaria Consortium | Malaria | 2023-07-15 | PHASE3 |
| NCT04703608 | London School of Hygiene and Tropical Medicine | Covid-19 | 2021-01-22 | PHASE3 |
| NCT00339417 | National Institute of Allergy and Infectious Diseases (NIAID) | Lymphatic Filariasis | 2006-02-22 | PHASE2 |
| NCT04041453 | Alejandro Krolewiecki|Brock University|Universidad Nacional del Centro de la Provincia de Buenos Aires|Universidad Nacional Autonoma de Honduras | Trichuris Infection|Helminthiasis | 2019-10-09 | PHASE2 |
| NCT04392713 | Combined Military Hospital, Pakistan | COVID | 2020-04-15 | NA |
| NCT04435587 | Mahidol University | Asymptomatic Infections|SARS-CoV2 Infection | 2020-07-13 | PHASE4 |
| NCT01066585 | Topaz Pharmaceuticals Inc | Head Lice | 2010-03 | PHASE3 |
| NCT01905436 | Washington University School of Medicine | Lymphatic Filariasis|Onchocerciasis|Soil Transmitted Helminth (STH) Infections | 2012-03 | |
| NCT04360356 | Tanta University | COVID-19 | 2020-05 | PHASE2|PHASE3 |
| NCT06557603 | Humanis Sagl?k Anonim Sirketi | Rosacea | 2024-03-06 | PHASE1 |
| NCT04049851 | Center for Research on Filariasis and Other Tropical Diseases, Cameroon | Onchocerciasis, Ocular|Loiasis | 2022-04-07 | PHASE2 |
| NCT05124691 | Barcelona Institute for Global Health|Leiden University Medical Center|Bahir Dar University|Centro de Investigacao em Saude de Manhica|London School of Hygiene and Tropical Medicine|Kenya Medical Research Institute|Laboratorios Liconsa|Universidad de León|European and Developing Countries Clinical Trials Partnership (EDCTP) | Helminthes; Infestation, Intestinal | 2022-01-20 | PHASE2|PHASE3 |
| NCT05362513 | Combined Military Hospital Abbottabad | Scabies | 2021-06-01 | PHASE1 |
| NCT03459794 | University of Georgia | Ivermectin | 2018-02-12 | EARLY_PHASE1 |
| NCT04844905 | London School of Hygiene and Tropical Medicine|Medical Research Council Unit, The Gambia|Ministerio de Saude Publica, Guinee-Bissau|Bandim Health Project|Instituto Nacional de Estudos e Pesquisas, Guinee-Bissau | Malaria,Falciparum|Neglected Tropical Diseases|Strongyloidiasis|Lymphatic Filariasis|Scabies|Hook Worm|Soil Transmitted Helminths | 2021-05-03 | PHASE3 |
| NCT06896929 | Children Hospital and Institute of Child Health, Lahore | Scabies | 2025-05-01 | PHASE2 |
| NCT07045493 | International Centre for Diarrhoeal Disease Research, Bangladesh|Cures Within Reach | Soil Transmitted Helminth (STH) Infections | 2025-07-10 | PHASE2 |
| NCT04591600 | Alkarkh Health Directorate-Baghdad | Covid19 | 2020-07-01 | PHASE1|PHASE2 |
| NCT05269030 | Menoufia University | Parosmia | 2022-07 | PHASE2 |
| NCT04275999 | Wake Forest University Health Sciences|Galderma R&D | Rosacea | 2021-04-16 | PHASE2 |
| NCT04343092 | University of Baghdad | COVID 19 | 2020-04-18 | PHASE1 |
| NCT04332068 | University of Oxford|Funda??o Alfredo da Matta (FUAM)|Kenya Medical Research Institute|Funda??o de Medicina Tropical Doutor Heitor Vieira Dourado (FMT-HVD)|Medical Research Center Unit The Gambia (MRCG) | Scabies | 2023-11-18 | PHASE2 |
| NCT03177993 | Washington University School of Medicine|The Task Force for Global Health|Murdoch Childrens Research Institute | Lymphatic Filariases|Scabies|Impetigo|Soil Transmitted Helminths | 2017-07-13 | NA |
| NCT04405843 | Centro de Estudios en Infectogía Pediatrica | COVID-19 | 2020-07-14 | PHASE2|PHASE3 |
| NCT00262418 | University Ghent | Scabies | 2004-07 | PHASE2 |
| NCT04434144 | Upazila Health & Family Planning Officer´s (UHFPO) Office, Chakoria, Cox´s Bazar | Ivermectin|Hydroxychloroquine|COVID19 | 2020-05-02 | |
| NCT04373824 | Max Healthcare Insititute Limited | COVID | 2020-04-25 | NA |
| NCT04716569 | South Valley University | Covid19 | 2021-01-20 | PHASE2|PHASE3 |
| NCT03432442 | Mahidol University | Dengue Hemorrhagic Fever | 2018-09-04 | PHASE2 |
| NCT01603251 | London School of Hygiene and Tropical Medicine|Radboud University Medical Center|Centre national de recherche et de formation sur le paludisme | Malaria | 2013-01 | PHASE1|PHASE2 |
| NCT04848688 | Jennifer Keiser|National Centre for Parasitology, Entomology and Malaria Control, Cambodia | Strongyloides Stercoralis Infection | 2022-02-05 | PHASE3 |
| NCT06497075 | Jennifer Keiser|Vector Borne & Neglected Tropical Disease Control Division, Ministry of Health, Uganda|Makerere University | Helminthiasis|Intestinal Worms | 2024-07-01 | |
| NCT04374019 | Susanne Arnold | COVID|Sars-CoV2 | 2020-05-01 | PHASE2 |
| NCT04703205 | Kitasato University | Covid19 | 2020-09-16 | PHASE2 |
| NCT01308268 | Universidad Nacional de Salta|Fundación Mundo Sano|Albert B. Sabin Vaccine Institute | Helminthiasis|Strongyloides Stercoralis Infection | 2010-12 | NA |
| NCT01068158 | Topaz Pharmaceuticals Inc | Head Lice | 2010-03 | PHASE3 |
| NCT02616250 | Galderma R&D | Rosacea | 2015-12 | PHASE4 |
| NCT04714515 | University of Sargodha|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine|Shaukat Khanum Memorial Cancer Hospital & Research Centre|Shanghai Jiao Tong University School of Medicine|Teesside University | Covid19|SARS-CoV-2 Infection | 2020-02-20 | |
| NCT07286604 | International Centre for Diarrhoeal Disease Research, Bangladesh | Post Kala Azar Dermal Leishmaniasis | 2022-03-02 | EARLY_PHASE1 |
| NCT00604084 | Edward Via Virginia College of Osteopathic Medicine | Scabies | 2007-05 | NA |
| NCT04729140 | Max Health, Subsero Health | Covid19 | 2020-12-28 | PHASE4 |
| NCT04530474 | Temple University | Covid19 | 2021-04-01 | PHASE3 |
| NCT04646109 | Afyonkarahisar Health Sciences University|NeuTec Pharma | COVID-19 | 2020-05-11 | PHASE3 |
| NCT04836299 | Universidad Mayor de San Simón|Barcelona Institute for Global Health|Université Catholique de Louvain | Covid19 | 2021-05-08 | PHASE2 |
| NCT01570504 | Centro per le Malattie Tropicali|European Commission | Strongyloidiasis | 2013-03 | PHASE3 |
| NCT04746365 | Elaraby Hospital|Shebin El-Kom Teaching Hospital | Covid19 | 2020-12-06 | PHASE4 |
| NCT03690453 | University of Oxford|Bill and Melinda Gates Foundation | Healthy | 2019-02-04 | PHASE4 |
| NCT04381884 | Laboratorio Elea Phoenix S.A.|Universidad Nacional de Salta|Centro de Investigación Veterinaria Tandil CIVETAN|Fundación Hospital de Pediatría Prof. Dr. Juan P. Garrahan|Universidad Nacional de Quilmes | COVID-19 Drug Treatment | 2020-05-18 | PHASE2 |
| NCT04422561 | Zagazig University | COVID | 2020-05-31 | PHASE2|PHASE3 |
| NCT05180461 | Drugs for Neglected Diseases|Bayer | Onchocerciasis | 2021-08-30 | PHASE2 |
| NCT03876262 | Medicines Development for Global Health | Onchocerciasis | 2021-05-03 | PHASE3 |
| NCT05605925 | Makerere University | Malaria | 2022-08-04 | PHASE4 |
| NCT04472585 | Sohaib Ashraf | Coronavirus Infection|COVID|Sars-CoV2 | 2020-11-14 | PHASE1|PHASE2 |
| NCT04391127 | Centenario Hospital Miguel Hidalgo | COVID-19 | 2020-05-04 | PHASE3 |
| NCT00819520 | Johnson & Johnson Consumer and Personal Products Worldwide | Lice Infestations | 2004-02 | PHASE3 |
| NCT02963324 | University Hospital, Basel, Switzerland | Malaria | 2016-11 | PHASE1 |
| NCT06265870 | Prince of Songkla University | Eosinophilia | 2024-05-01 | NA |
| NCT02735707 | UMC Utrecht|Australian and New Zealand Intensive Care Research Centre|Medical Research Institute of New Zealand|Unity Health|Berry Consultants|Global Coalition for Adaptive Research|University of Pittsburgh Medical Center|Intensive Care National Audit & Research Centre|St. Marianna University School of Medicine|Nat Intensive Care Surveillance - MORU|National University Hospital, Singapore | Community-acquired Pneumonia, Influenza, COVID-19 | 2016-04-11 | PHASE3 |
| NCT02036229 | Rabin Medical Center | Demodicidosis|Rosacea | 2014-02 | PHASE3 |
| NCT02046200 | University of California, Los Angeles | Alcohol Use Disorder | 2014-02 | PHASE1|PHASE2 |
| NCT04429711 | Sheba Medical Center | COVID-19 | 2020-05-12 | NA |
| NCT03286101 | United Laboratories | Pediculosis Capitis | 2017-09-14 | PHASE2 |
| NCT00857948 | Topaz Pharmaceuticals Inc | Pediculus Humanus Capitis (Head Lice) | 2009-03 | PHASE2 |
| NCT05198947 | B.P. Koirala Institute of Health Sciences | Scabies | 2017-01 | NA |
| NCT02775617 | London School of Hygiene and Tropical Medicine|Atoifi Adventist Hospital, Solomon Islands|Kirby Institute|Murdoch Childrens Research Institute | Scabies|Yaws|Impetigo | 2016-07 | PHASE4 |
| NCT06033352 | Insel Gruppe AG, University Hospital Bern | Rosacea | 2023-09-12 | PHASE2 |
| NCT01050452 | DBL -Institute for Health Research and Development | Parasitic Diseases | 2007-10 | NA |
| NCT00921154 | Johnson & Johnson Consumer and Personal Products Worldwide | Healthy | 2005-03 | PHASE1 |
| NCT04832945 | Grupo Rescue S.A.S República Dominicana | Covid19 | 2020-06-29 | |
| NCT05045937 | Patrick Robinson | Covid19|COVID-19 Pneumonia|COVID-19 Respiratory Infection|COVID-19 Acute Bronchitis | 2022-05-01 | |
| NCT01493687 | Galderma R&D | Papulopustular Rosacea (PPR) | 2011-12 | PHASE3 |
| NCT03034460 | Galderma R&D | Acne | 2016-04-25 | PHASE2 |
| NCT01494467 | Galderma R&D | Papulopustular Rosacea | 2011-12 | PHASE3 |
| NCT03250624 | Galderma R&D | Atopic Dermatitis | 2016-11-01 | PHASE2 |
| NCT05056883 | Kowa Company, Ltd. | Covid19 | 2021-10-22 | PHASE3 |